 Brian Hemstreet
Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Pharmacy | 2 | 2022 | 128 | 0.820 |
Why?
| | Faculty, Pharmacy | 1 | 2022 | 17 | 0.810 |
Why?
| | Deglutition Disorders | 1 | 2023 | 119 | 0.780 |
Why?
| | Eosinophilic Esophagitis | 1 | 2023 | 295 | 0.640 |
Why?
| | Heterocyclic Compounds, 4 or More Rings | 1 | 2016 | 16 | 0.560 |
Why?
| | Carbamates | 1 | 2016 | 35 | 0.550 |
Why?
| | Sofosbuvir | 1 | 2016 | 54 | 0.540 |
Why?
| | Hepacivirus | 1 | 2016 | 234 | 0.490 |
Why?
| | Hepatitis C | 1 | 2016 | 229 | 0.450 |
Why?
| | Glucocorticoids | 2 | 2006 | 551 | 0.390 |
Why?
| | Antiviral Agents | 1 | 2016 | 651 | 0.370 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2006 | 1115 | 0.290 |
Why?
| | Hypophosphatemia | 1 | 2006 | 18 | 0.280 |
Why?
| | Hypokalemia | 1 | 2006 | 25 | 0.280 |
Why?
| | Phosphorus | 1 | 2006 | 81 | 0.270 |
Why?
| | Potassium | 1 | 2006 | 128 | 0.270 |
Why?
| | Drug Utilization Review | 1 | 2006 | 57 | 0.260 |
Why?
| | Medical Informatics | 1 | 2006 | 94 | 0.260 |
Why?
| | Prednisone | 1 | 2006 | 232 | 0.250 |
Why?
| | Drug Hypersensitivity | 1 | 2006 | 86 | 0.240 |
Why?
| | Drug Interactions | 1 | 2006 | 347 | 0.240 |
Why?
| | Acidosis, Renal Tubular | 1 | 2004 | 6 | 0.240 |
Why?
| | Drug Administration Schedule | 3 | 2016 | 724 | 0.230 |
Why?
| | Carbazoles | 1 | 2004 | 80 | 0.220 |
Why?
| | Anti-Infective Agents | 1 | 2006 | 225 | 0.220 |
Why?
| | Propanolamines | 1 | 2004 | 94 | 0.220 |
Why?
| | Hypertension, Portal | 1 | 2004 | 62 | 0.220 |
Why?
| | Sulfonamides | 1 | 2006 | 447 | 0.210 |
Why?
| | Proton Pump Inhibitors | 1 | 2023 | 96 | 0.200 |
Why?
| | Sucralfate | 1 | 2001 | 4 | 0.190 |
Why?
| | Anti-Ulcer Agents | 1 | 2001 | 16 | 0.190 |
Why?
| | Cyclohexanecarboxylic Acids | 1 | 2001 | 22 | 0.190 |
Why?
| | Amines | 1 | 2001 | 37 | 0.190 |
Why?
| | Faculty | 1 | 2022 | 131 | 0.190 |
Why?
| | Clinical Trials as Topic | 3 | 2016 | 944 | 0.180 |
Why?
| | Acetates | 1 | 2001 | 96 | 0.180 |
Why?
| | Diabetic Neuropathies | 1 | 2001 | 79 | 0.180 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2001 | 151 | 0.180 |
Why?
| | Delivery of Health Care | 1 | 2006 | 847 | 0.170 |
Why?
| | Adrenal Cortex Hormones | 1 | 2023 | 510 | 0.170 |
Why?
| | Anticonvulsants | 1 | 2001 | 182 | 0.160 |
Why?
| | Treatment Outcome | 2 | 2016 | 9163 | 0.160 |
Why?
| | Education, Pharmacy, Graduate | 2 | 2016 | 21 | 0.150 |
Why?
| | Pharmacy Residencies | 1 | 2016 | 12 | 0.130 |
Why?
| | Drug Combinations | 1 | 2016 | 289 | 0.130 |
Why?
| | Kidney Failure, Chronic | 1 | 2001 | 491 | 0.130 |
Why?
| | Hospitals, University | 2 | 2006 | 172 | 0.130 |
Why?
| | Certification | 1 | 2016 | 90 | 0.130 |
Why?
| | Humans | 14 | 2023 | 115859 | 0.120 |
Why?
| | Anti-Bacterial Agents | 1 | 2004 | 1486 | 0.120 |
Why?
| | Drug Prescriptions | 2 | 2006 | 241 | 0.120 |
Why?
| | Adult | 5 | 2023 | 30814 | 0.120 |
Why?
| | Problem-Based Learning | 1 | 2014 | 77 | 0.110 |
Why?
| | Acute Disease | 2 | 2006 | 917 | 0.110 |
Why?
| | Students, Pharmacy | 1 | 2014 | 100 | 0.110 |
Why?
| | Quality of Life | 1 | 2023 | 2390 | 0.100 |
Why?
| | Teaching | 1 | 2014 | 226 | 0.100 |
Why?
| | Genotype | 1 | 2016 | 1830 | 0.100 |
Why?
| | Interpersonal Relations | 1 | 2014 | 342 | 0.090 |
Why?
| | Hospitalization | 2 | 2006 | 1764 | 0.070 |
Why?
| | Antihypertensive Agents | 1 | 2010 | 432 | 0.070 |
Why?
| | Hospital Bed Capacity, 300 to 499 | 1 | 2006 | 5 | 0.070 |
Why?
| | Middle Aged | 3 | 2016 | 27078 | 0.070 |
Why?
| | Internship, Nonmedical | 1 | 2006 | 18 | 0.070 |
Why?
| | Drug Administration Routes | 1 | 2006 | 41 | 0.070 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2006 | 39 | 0.070 |
Why?
| | Infusions, Intravenous | 1 | 2006 | 374 | 0.070 |
Why?
| | Patient Care | 1 | 2006 | 103 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2006 | 6434 | 0.060 |
Why?
| | Drug Utilization | 1 | 2006 | 167 | 0.060 |
Why?
| | Kidney Transplantation | 1 | 2010 | 559 | 0.060 |
Why?
| | Adrenergic Antagonists | 1 | 2004 | 9 | 0.060 |
Why?
| | Male | 4 | 2016 | 56103 | 0.060 |
Why?
| | Aged | 3 | 2006 | 19292 | 0.060 |
Why?
| | Child | 1 | 2023 | 18537 | 0.060 |
Why?
| | Propranolol | 1 | 2004 | 53 | 0.060 |
Why?
| | Esophageal and Gastric Varices | 1 | 2004 | 33 | 0.060 |
Why?
| | Pharmacists | 1 | 2006 | 237 | 0.060 |
Why?
| | Interviews as Topic | 1 | 2006 | 595 | 0.060 |
Why?
| | Recurrence | 1 | 2006 | 950 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2004 | 163 | 0.050 |
Why?
| | Practice Guidelines as Topic | 2 | 2010 | 1405 | 0.050 |
Why?
| | Retrospective Studies | 3 | 2014 | 12615 | 0.050 |
Why?
| | Hypertension | 1 | 2010 | 1065 | 0.050 |
Why?
| | Societies, Pharmaceutical | 2 | 2016 | 27 | 0.050 |
Why?
| | Fibrosis | 1 | 2004 | 458 | 0.050 |
Why?
| | Aluminum | 1 | 2001 | 34 | 0.050 |
Why?
| | Risk Assessment | 1 | 2006 | 2992 | 0.040 |
Why?
| | Colorado | 1 | 2006 | 4122 | 0.030 |
Why?
| | Female | 3 | 2006 | 60070 | 0.030 |
Why?
| | Specialization | 1 | 2016 | 117 | 0.030 |
Why?
| | Prospective Studies | 1 | 2006 | 6276 | 0.030 |
Why?
| | Risk Factors | 1 | 2006 | 8715 | 0.030 |
Why?
| | Comprehension | 1 | 2014 | 159 | 0.030 |
Why?
| | Educational Status | 1 | 2014 | 413 | 0.030 |
Why?
| | Educational Measurement | 1 | 2014 | 265 | 0.020 |
Why?
| | Communication | 1 | 2014 | 749 | 0.020 |
Why?
| | Adolescent | 1 | 2006 | 17935 | 0.020 |
Why?
| | Curriculum | 1 | 2014 | 856 | 0.020 |
Why?
| | Graft Rejection | 1 | 2010 | 533 | 0.020 |
Why?
| | Professional Practice | 1 | 2006 | 63 | 0.020 |
Why?
| | Blood Pressure | 1 | 2010 | 1537 | 0.010 |
Why?
| | United States | 1 | 2006 | 12319 | 0.010 |
Why?
|
|
Hemstreet's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|